Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7168813 | 0.83 | SLC6A2 (0.54) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL11154625 | 0.79 | SLC6A2 (0.50) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| SCHEMBL447982 | 0.78 | EPHX1 (0.64) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| SCHEMBL172932 | 0.78 | EPHX1 (0.64) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| SCHEMBL172909 | 0.78 | EPHX1 (0.64) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| SCHEMBL16435072 | 0.78 | TAAR1 (0.61) | SLC6A2TAAR1OPRK1SLC7A5 | |
| SCHEMBL28757752 | 0.78 | TAAR1 (0.48) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| Dimetamfetamine SCHEMBL5088134 | 0.77 | SLC6A4 (0.64) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL5640811 | 0.77 | EPHX1 (0.61) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 | |
| SCHEMBL27638171 | 0.77 | ALPI (0.56) | SLC6A2SIGMAR1TAAR1SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242694-A1 | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith | D SIDOCKY NEIL R | 2008-10-02 | — | — | US | disclosed |
| WO-2008036308-A2 | AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-03-27 | — | — | WO | disclosed |
| EP-1742918-A1 | LXR RECEPTOR MODULATORS | LABORATOIRES FOURNIER S.A. (FR) | 2007-01-17 | — | — | EP | disclosed |
| WO-2005121093-A1 | LXR RECEPTOR MODULATORS | LABORATOIRES FOURNIER S.A. (FR) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242694-A1 | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith | JAK2, CHEK2, MTOR | SLC6A2 4753/4885SIGMAR1 3478/4885TAAR1 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.